Pilot randomized controlled study of a histamine receptor inverse agonist in the symptomatic treatment of AD

Michael Egan, Roy Yaari, Lian Liu, Michael Ryan, Yahong Peng, Christopher Lines, David Michelson

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)481-490
Number of pages10
JournalCurrent Alzheimer Research
Volume9
Issue number4
DOIs
StatePublished - May 2012
Externally publishedYes

ASJC Scopus Subject Areas

  • Neurology
  • Clinical Neurology

Keywords

  • Alzheimer's disease
  • Histamine subtype-3 receptor
  • MK-0249
  • Randomized trial

Cite this